Skip to main content
Back
Watch Compare

Cocrystal Pharma, Inc.

Data quality: 83%
COCP
Nasdaq Manufacturing Chemicals
$1.25
▼ $0.18 (-12.59%)
Mkt Cap: 20.13 M
Price
$1.46
Mkt Cap
20.13 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Negative free cash flow of -8.20 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-135.84%
Below sector avg (-53.34%)
ROIC-91.35%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio5.78
Interest Coverage-67.31

Valuation

PE (TTM)
-2.28
Below sector avg (-1.47)
P/B Ratio2.62
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -2.3 -1.5
P/B 2.6 1.6
ROE % -135.8 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Analyst Price Target

3 analysts
Buy
Current
$1.25
+540.0%
Target
$8.00
$6.00
$8.00
$10.00
Forecast
Forward P/E -1.29
Forward EPS -$0.97
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$0.97
-$0.97 – -$0.97
 0.0 1
FY2026 -$0.61
-$0.61 – -$0.61
 0.0 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$0.18 -$0.17 +2.9%
Q32025 -$0.22 -$0.19 +11.6%
Q22025 -$0.30 -$0.20 +33.3%
Q12025 -$0.51 -$0.23 +54.5%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -8.83 M
ROE -135.84% ROA -93.20%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -8.20 M
ROIC -91.35% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 5.78
Interest Coverage -67.31 Asset Turnover N/A
Working Capital 7.26 M Tangible Book Value 7.67 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.28 Forward P/E N/A
P/B Ratio 2.62 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -40.76%
Market Cap 20.13 M Enterprise Value 20.13 M
Per Share
EPS (Diluted TTM) -0.78 Revenue / Share N/A
FCF / Share -0.60 OCF / Share -0.59
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 92.90%
SBC-Adj. FCF -8.67 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — 2.01 M
Net Income -8.83 M -17.50 M -17.98 M -38.84 M -14.19 M
EPS (Diluted) -0.78 -1.72 -1.87 — —
Gross Profit — — — — —
Operating Income -9.02 M -17.88 M -18.56 M -38.83 M -14.22 M
EBITDA — — — — —
R&D Expenses 5.06 M 12.54 M 15.17 M 12.39 M 8.79 M
SG&A Expenses — — — — —
D&A 72,000.0 126,000.0 189,000.0 185,000.0 190,000.0
Interest Expense -134,000.0 -537,000.0 -640,000.0 2,000.0 4,000.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 9.71 M 13.46 M 31.26 M 40.84 M 79.39 M
Total Liabilities 3.38 M 3.93 M 4.88 M 1.27 M 1.84 M
Shareholders' Equity 6.33 M 9.52 M 26.38 M 39.57 M 77.55 M
Total Debt — — — — —
Cash & Equivalents 7.03 M 9.86 M 26.35 M 37.22 M 58.71 M
Current Assets 8.13 M 11.58 M 29.09 M 40.18 M 59.32 M
Current Liabilities 2.21 M 2.43 M 3.26 M 1.22 M 1.55 M